Outsourcing-Pharma’s Post

The events of the past few days have made it abundantly clear: it’s time to redefine leadership and workplace culture. We need to create spaces where everyone feels heard, valued, and empowered. True leadership is about adaptability, inspiration, and the ability to recognize potential beyond labels. As we move forward, internalized misogyny and transphobia must have no place in our workplaces. Sharing power isn’t a threat, it’s an opportunity to broaden our thoughts and perspectives. Diversity and inclusion are not just buzzwords but essential to driving innovation and progress. Diverse experiences are what shape systems, communities, and industries. Now is the time to stand up for who we are and what we believe in. As we continue working to close the gender gap in leadership, let’s support one another. It’s not about taking power—it’s about sharing it for the greater good. In this spirit, I had the privilege of speaking with Avencia Sanchez-Mejias PhD, CEO and Co-founder of Integra Therapeutics. Avencia is at the forefront of driving diversity and inclusion in science and tech, and her journey is a powerful example of how embracing diversity not only fosters scientific progress but also creates new opportunities and drives meaningful change. Happy reading!

**Anne Wojcicki: A Trailblazer in Life Science and Technology** Anne Wojcicki is a visionary entrepreneur, scientist, and investor who has made significant contributions to the fields of life science and technology. Her journey is an inspiring story of determination, innovation, and the power of collaboration. **Early Life and Education:** Born in Palo Alto, California, Anne earned her bachelor's degree in biology from Yale University and later pursued a doctorate in molecular biology and genetics from the University of California, San Diego. Her passion for science and research led her to pursue a career in biotechnology. **Co-founding 23andMe:** In 2006, Anne co-founded 23andMe, a personal genomics and biotechnology company that revolutionized the field of personalized medicine. 23andMe offers DNA testing services that empower individuals to understand their genetic predispositions, health risks, and ancestry. **Empowering Individuals through Genetics:** Anne's vision for 23andMe was to make genetic information accessible and affordable to everyone. She believed that by empowering individuals with knowledge of their own genetics, they could make informed healthcare decisions and improve their overall well-being. **Building Partnerships and Collaborations:** To drive innovation and advance the field of genomics, Anne has forged partnerships with leading research institutions, pharmaceutical companies, and policymakers. These collaborations have enabled 23andMe to contribute to groundbreaking discoveries and develop personalized therapies. **Commitment to Diversity and Inclusion:** Anne is a vocal advocate for diversity and inclusion in science and technology. She has established programs and initiatives to support underrepresented groups and create a more equitable and inclusive environment. **Impact and Recognition:** Anne's contributions have been recognized with numerous awards and accolades. She is a member of the National Academy of Sciences, a recipient of the Horatio Alger Award, and was named one of Time magazine's 100 Most Influential People. **Inspiring Future Generations:** Anne's passion for science and her dedication to making a positive impact in the world serve as an inspiration for countless young scientists and entrepreneurs. She is a role model for women in STEM and a testament to the power of collaboration and innovation in driving social change. Anne Wojcicki is a role model for women in science and technology. Who are some other inspiring women in STEM whose stories should be highlighted? Share their names and achievements below! #womeninstem #lifescience #genomics #personalizedmedicine #diversityintech #innovation

Great article highlighting women leaders in life sciences for 2024, celebrating their contributions to innovation, business growth, and healthcare impact. It showcases diverse achievements across pharmaceuticals, biotech, and related fields, emphasizing leadership, ground-breaking research, and advancements in medicine and patient care. For the full details, you can explore the article: https://lnkd.in/ey6qSGUF #womeninstem #divesity #DEI #femaleleaders

Did you hear that Dan Jing Wu, CEO & Co-Founder VivArt-X, is one of the 5️⃣0️⃣ Global Rising Stars in ESG of 2024? ⭐ Congratulations on this much-deserved recognition! "What a remarkable week! Received the amazing news of being selected as one of the 50 global Rising Stars in ESG 2024 by the Women of the Future Programme! It’s truly an honor, and to top it off, being mentioned in the Financial Times UK is a bucket-list moment," says Dan Jing Wu after the list announcement. ESG stands for Environmental, Social and Governance. In the words of the program, "ESG is a wide-ranging and fast-moving field. It provides a framework for assessing how a company is performing against its commitments to shape a better world." The annual list seeks to celebrate the talented female trailblazers and role models aged 35 and under from around the world who are at the forefront of ESG. In Dan Jing Wu's profile, she was asked about the defining moment that inspired her to pursue an ESG related career? Here's what she said: "It was my childhood dream to help and heal people when they became sick, inspired by witnessing a family member struggle with illness. After completing my PhD in biomedical engineering, I aimed to bring innovative techniques to patients. That is how VivArt-X came to life." VivArt-X develops personalized, regenerative materials for women's health. Its revolutionary synthetic, degradable biomaterial will revolutionize breast reconstructive surgery in women who have undergone breast tissue removal after breast cancer diagnosis, offering personalized breast reconstruction and regeneration. For more information on the list, click here > https://lnkd.in/etwPykR9 #borskifund #femalefounders #innovation #venturecapital #impactinvesting #startup

🗞 For the June edition of Drug Target Review's Women in STEM series, our CEO Joanne Kanaan shares her journey from education to entrepreneurship, the challenges she has faced in her career and the strengths of having a STEM background in founding a startup. "Whether a man or a woman, I think that having a STEM background gives unique problem-solving skills, high resilience to failure, and a framework to tackle issues differently. In STEM, we are trained to both look for as much information as possible, but to also follow hunches and intuitions, otherwise no new discoveries would be made. This unique skillset combination is very handy in my role as an early stage startup founder where we face the unknown regularly, and have to deal with rejection from investors, hurdles in our tech development, a very steep learning curve, etc." Read the full article 👇 https://lnkd.in/eysNySTj #WomenInSTEM #bloodtesting #deeptech #medtech #entrepreneur #pointofcare #chronicdisease #heartfailure

Hi everyone! It's been a while since I worked on some exciting multi-specific biotech designs. Now, I'm excited to share some technical data from these projects: 1️⃣ Development of bispecific NK cell/SARS-CoV-2 engaging fusion protein 2️⃣ Trifunctional strategy for simultaneous cancer recognition, immune engagement, and activation The leaflet explore innovative approaches in immunotherapy and biodesign. As I have gradually moved towards helping others in building their own genetic designs, we’re now working on a computational research tool to replicate and enhance the workflow of constructing and engineering these biological models. I believe this tool could empower researchers tackling similar challenges, enabling faster iterations and deeper insights. These technologies were meant to be part of a greater technology transfer process in the country by an organization that unfortunately hasn’t moved forward with its development. Instead of letting it sit idle, I’m committed to sharing what I’ve learned and coaching others to apply these strategies in their work. I’d love to hear your thoughts: 1. Would open-sourcing the sequence of these constructs provide more value to the community than keeping them in a facility that doesn’t utilize them effectively? 2. Are these resources something you could benefit from in your own projects? If you’re interested in learning more or collaborating, feel free to reach out—I’d be happy to share additional details and brainstorm how we can push innovation forward together. #Biodesign #Immunotherapy #Collaboration #OpenAccess #Innovation

Greetings, I'm Mohammad Samiullah, and I have three years of experience as a content writer. I can provide you with customized, high-quality material to assist you succeed in your SEO campaigns. This is how I can help you: Writing for SEO: Research Writing: Ideas: Writing Reports: Presentation Techniques: well-versed in various reference formats, including APA and Harvard MLA Illinois Oscula IEEE delivering high-quality material free of plagiarism AI 0% timely delivery Extensive research and well-structured

Celebrating this week's Woman in Tech 🥳: Meet Nabiha Saklayen, CEO and co-founder of Cellino, a company developing AI-powered biomanufacturing systems for personalized cell therapies. Saklayen’s goal is to revolutionize the treatment landscape for diseases such as Parkinson's, heart disease, and diabetes by making personalized cell therapies more accessible and affordable. Background and Early Life: Born in Riyadh to Bangladeshi parents, Saklayen's childhood was truly international, with time spent in Bangladesh, Germany, and Sri Lanka. Education and Achievements: Saklayen completed her BS at Emory University and her Ph.D. in Physics from Harvard University. Her achievements include: ► MIT Tech Review's 35 Innovators Under 35 list for her patented inventions in cellular laser editing ► 30 Under 30 Healthcare list ► Inaugural Tory Burch Foundation Fellow in Genomics at the Innovative Genomics Institute, led by Nobel Laureate Dr. Jennifer Doudna In 2017, Saklayen co-founded Cellino Biotech to revolutionize cell therapy. ► The company combines stem cell biology, laser physics, and machine learning to increase production efficiency. ► Cellino has raised $97.2 million from notable investors like Khosla and Bayer and was just awarded a $25 million grant from ARPA-H for stem cell research. Saklayen's story is incredibly inspiring. 😎 It's amazing to see a woman leading the charge in such a cutting-edge and interdisciplinary field in AI and healthcare. #artificialintelligence #womenintech #healthcare

I just heard about the Femtech World Awards 2025 which is going to celebrate the brightest lights in women's health innovation. With all that is going on, I'm a big fan of cheering on the innovators and leaders who are working tirelessly to champion women's health. Will you join me in nominating your favorite leaders who are the best examples of leadership, innovation and impact in key areas that affect women's health and wellbeing? Learn more here >>> https://lnkd.in/gqtkq6d7

Unleashing Potential at Chile TechWeek This week at Chile TechWeek, we're not just celebrating innovation and entrepreneurship—we're actively engaging in it. Conversing with some of the brightest minds, I’ve been transforming insightful remarks into aforisms, sharing these gems on my dedicated Instagram account, @biotechpoet. Here are some of the standout insights: - Inflammation as the Root: Once more, we are reminded that inflammation underlies numerous diseases, highlighting the intricate balance of our bodily functions. - Aging Redefined: Aging is not just about time passing; it's intricately linked to how our bodies handle oxidation. - Pioneering Transplant: A woman in China has bid farewell to type 1 diabetes through a groundbreaking stem cell transplant, paving the way for future medical breakthroughs. - ADAR's Promise: Poised to outshine CRISPR, ADAR (adenosine deaminases acting on RNA) is setting the stage for next-level genetic editing. - Big Idea Ventures & Nalca Bio: Demonstrating confidence in Chilean innovation, Big Idea Ventures is making strategic early investments in startups like Nalca Biotech. - Semaglutide's Impact: Revolutionizing weight loss, semaglutide has caused notable shifts in food sales dynamics, even influencing major retailers like Walmart. - FDA's Record Year: With 71 new approvals in 2023, including pioneering gene and CRISPR therapies, this year marks a historic surge in medical advancements. The convergence of such dynamic ideas at Chile TechWeek underscores the incredible power of collaboration. It’s thrilling to witness and be part of the swift progress brought about when brilliant minds unite. The pace of change is accelerating, and with it, our march towards a brighter, healthier future. Let’s keep igniting the sparks of innovation and watching the magic unfold in real-time!  Follow @biotechpoet on Instagram for more aphoristic takes on the pulse of biotech. #ChileTechWeek #Innovation #Biotechnology #HealthcareInnovation #Entrepreneurship #ZentynelVC #ScienceAndBusiness